75岁及以上肥厚型梗阻性心肌病患者酒精室间隔消融术的结局
该回顾性单中心研究纳入1997年至2021年接受酒精室间隔消融术(ASA)的肥厚型梗阻性心肌病(HOCM)患者,比较≥75岁与<75岁患者的结局。结果显示两组院内死亡率相似,≥75岁组随访时运动诱发左室流出道压差更低,但高度房室传导阻滞发生率更高。
要点
- ≥75岁患者ASA术后院内死亡率与年轻患者无差异。
- ≥75岁患者术后高度房室传导阻滞发生率高于年轻患者。
- ≥75岁患者随访时运动诱发左室流出道压差低于年轻患者。
核心结论
- ≥75岁患者接受ASA的疗效和院内死亡率与年轻患者相似,但高度房室传导阻滞需永久起搏器植入的比例更高。
研究设计与样本
- 回顾性单中心分析,纳入1997年9月1日至2021年7月31日连续接受ASA的HOCM患者,左室流出道压差≥50 mm Hg。
- 比较≥75岁组(208例)与<75岁组(1430例)基线和6个月后的超声心动图、手术及临床参数。
主要发现
- ≥75岁组女性占85.1%,年龄78.0岁(IQR 76.0-80.0);<75岁组女性占42.0%,年龄56.0岁(IQR 46.0-65.0)。
- 基线6分钟步行试验距离≥75岁组为317.0 m(IQR 242.0-389.0),<75岁组为438.0 m(IQR 353.3-504.0),p<0.0001。
- 随访时运动诱发左室流出道压差≥75岁组为29.5 mm Hg(IQR 18.0-54.0),<75岁组为39.5 mm Hg(IQR 23.0-73.8),p=0.0007。
- 术后高度房室传导阻滞≥75岁组为25.5%,<75岁组为13.6%,p<0.0001。
- 院内死亡率≥75岁组为1.0%,<75岁组为0.6%,p=0.6580。
临床怎么用
- 对于≥75岁HOCM患者,ASA可作为改善流出道梗阻的治疗选择,但需警惕术后高度房室传导阻滞风险。
局限性
- 回顾性单中心设计,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Outcome data for patients ≥75 years with hypertrophic obstructive cardiomyopathy (HOCM) undergoing alcohol septal ablation (ASA) are lacking. Therefore, a retrospective single-centre analysis was conducted. METHODS: The data of all consecutive ASAs, that were performed at our institution between 1 September 1997 and 31 July 2021 in patients with HOCM with left ventricular outflow tract gradients (LVOTG) ≥50 mm Hg, were collected from patient reports. ASA was performed per institutional standards with 95% ethanol infused into a feasible septal branch. Differences regarding echocardiographic, procedural and clinical parameters at baseline and after 6 months between patients ≥75 years and <75 years were assessed. RESULTS: We found 208 ASAs in patients ≥75 years (85.1% female; age 78.0 years (IQR 76.0-80.0)) and 1430 ASAs in patients <75 years (42.0% female; age 56.0 years (IQR 46.0-65.0)). Patients ≥75 years had lower distances in 6 min walk test (baseline: 317.0 m (IQR 242.0-389.0) vs 438.0 m (IQR 353.3-504.0); p<0.0001). Exercise-induced LVOTG calculated at follow-up was lower in patients ≥75 years (29.5 mm Hg (IQR 18.0-54.0) vs 39.5 mm Hg (IQR 23.0-73.8); p=0.0007). There were more high-degree AV blocks after ASA in patients ≥75 years (25.5% vs 13.6%; p<0.0001). The in-hospital mortality did not differ between the groups (age ≥75 years: 1.0%; age <75 years: 0.6%; p=0.6580). CONCLUSION: ASA had similar efficacy and intrahospital mortality in patients ≥75 years compared with younger patients. Higher rates of AV block with need for permanent pacemaker implantation were observed in patients ≥75 years of age.
引用
- Lawin D, Stellbrink C, Stellbrink E, et al. Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy. Heart. 2023. PMID: 37460195. doi:10.1136/heartjnl-2023-322659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。